Skip to main content
. 2022 Jul 26;13:940094. doi: 10.3389/fimmu.2022.940094

Figure 1.

Figure 1

Liver preservation and NMP protocol. Emricasan (5mg/kg liver) or vehicle control (1mL DMSO) was added to the circulating perfusate immediately prior to connection of the liver to the NMP device. Serial tissue biopsies and perfusate samples were taken at indicated time points for subsequent analysis. * indicates a discordance between EM perfusions (bile samples taken at 3, 6, 9, and 12 hours) and control perfusions (bile samples taken at 4, 8, and 12 hours). NMP, normothermic machine perfusion; WIT, warm ischemic time; CIT, cold ischemic time; RNAseq, bulk RNA sequencing.